Foley & Lardner’s Top Trends for 2024 publication unpacks key developments in an uncertain regulatory landscape.
The 2024 Health Care & Life Sciences Top Trends Report includes the following articles.
- Health Care Litigation: Overview and Assessment of the Impact of Artificial Intelligence
- Litigation Trends: How Court Decisions Will Affect Pharmaceutical Manufacturers
- Balancing Innovation and Safety: FDA Regulation of AI in Medical Devices
- Intellectual Property Strategies for Digital Health AI Companies: Increasing Valuation and Creating Barriers for Competitors
- FDA and FTC Poised to Regulate Social Media Advertising of Drugs and Digital Health Services
- FDA Regulation of Cosmetics – The Beauty or the Beast
- Telemedicine Companies Increasingly Shift from Cash-Only Direct-to-Consumer Models to Third-Party Reimbursement
- Diversity in Clinical Trials
- Medicare Advantage Marketing Under Pressure
- 2024 Will Be a Critical Year for the 340B Drug Pricing Program
- Health Care Joint Ventures are Heating Up. Here’s What Providers Need to Know
Members-only access
To access the full resource, you must be a
member.
Already a member?
Login to unlock.
Login
Not an ACC member?
Gain access to a comprehensive collection of global
resources for in-house counsel
Sign
up for a 30-day trial
The information in any resource collected in this virtual library should
not be construed as legal advice or legal opinion on specific facts and should not be considered representative of the views of its authors, its sponsors, and/or ACC. These resources are not intended as a definitive statement on the subject addressed. Rather, they are intended to serve as a tool providing practical advice and references for the busy in-house practitioner and other readers.
Sponsored By
